Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults-Reference-Cited by-同舟云学术

Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

Published:2018-03-04 Issue:5 Volume:38 Page:815-832
ISSN:0333-1024
Container-title:Cephalalgia
language:en
Short-container-title:Cephalalgia

Author:

Tassorelli Cristina¹²^ORCID,Diener Hans-Christoph³^ORCID,Dodick David W⁴^ORCID,Silberstein Stephen D⁵,Lipton Richard B⁶,Ashina Messoud⁷,Becker Werner J⁸⁹,Ferrari Michel D¹⁰,Goadsby Peter J¹¹^ORCID,Pozo-Rosich Patricia¹²¹³,Wang Shuu-Jiun¹⁴,

Affiliation:

1. Headache Science Center, C. Mondino Foundation, Pavia, Italy

2. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy

3. Department of Neurology, University Hospital Essen, Essen, Germany

4. Department of Neurology, Mayo Clinic, Phoenix, AZ, USA

5. Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA

6. Montefiore Headache Center, Department of Neurology and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, NY, USA

7. Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark

8. Dept of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada

9. Hotchkiss Brain Institute, Calgary, Alberta, Canada

10. Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands

11. National Institute for Health Research-Wellcome Trust King’s Clinical Research Facility, King’s College Hospital, London, England

12. Headache Research Group, VHIR, Universitat Autònoma de Barcelona, Barcelona Spain

13. Neurology Department, Hospital Vall d’Hebron, Barcelona, Spain

14. Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan

Abstract

Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.

Publisher

SAGE Publications

Subject

Neurology (clinical),General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0333102418758283

Reference66 articles.

1. Guidelines for Controlled Trials of Drugs in Cluster Headache: First Edition: International Headache Society Committee on Clinical Trials in Cluster Headache

2. Guidelines for Trials of Drug Treatments in Tension-Type Headache

3. Guidelines for Controlled Trials of Drugs in Migraine: Second Edition

4. Guidelines for Controlled Trials of Drugs in Tension-Type Headache: Second Edition

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial;Headache: The Journal of Head and Face Pain;2024-09-02

2. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

3. Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile;The Journal of Headache and Pain;2024-08-27

4. Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management;Nature Reviews Neurology;2024-08-19

5. Documento de consenso de la Sociedad Española de Neurología (SEN), Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC), Sociedad de Medicina de Atención Primaria (SEMERGEN) y Asociación Española de Migraña y Cefalea (AEMICE) sobre el tratamiento de la migraña;Medicina Clínica;2024-08